lobbying_activities: 2029641

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2029641	574a0d61-84f1-4ab3-87a0-34c8aaf9b702	Q3	ROCK & ASSOCIATES	33545	DIAMONDBACK DRUGS	2017	third_quarter	PHA	Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.	HOUSE OF REPRESENTATIVES,SENATE	11250		0	0	2017-10-18T12:30:16.357000-04:00